HIV & AIDS

Therapeutic HIV vaccine achieves encouraging results

A phase I/IIa clinical trial that the University of Oxford collaborated on has demonstrated that a T-cell therapeutic HIV vaccine was associated with better control of the virus rebound when antiretroviral therapy (ART) was ...

Diseases, Conditions, Syndromes

Infections reported after single dose of monkeypox vaccine

Most cases of monkeypox that occur after vaccination with the modified Vaccinia Ankara-Bavarian Nordic vaccine (MVA-BN) occur within 14 days of receipt of the first dose, according to a research letter published online Sept. ...

Diseases, Conditions, Syndromes

US may expand monkeypox vaccine eligibility to men with HIV

U.S. officials are considering broadening recommendations for who gets vaccinated against monkeypox, possibly to include many men with HIV or those recently diagnosed with other sexually transmitted diseases.

HIV & AIDS

Vaccination for HIV shows promise in rhesus macaques

A team of researchers affiliated with several institutions in the U.S. has developed a vaccine for HIV that shows promise in rhesus macaques. In their paper published in the journal Science Translational Medicine, the group ...

page 3 from 27